Dr. K. Gus Kousoulas, PhD
Director, Divison of Biotechnology and Molecular Medicine Professor Department of Pathobiological Sciences Louisiana State University School of Veterinary Medicine Phone: 225-578-9683 Email: vtgusk@lsu.edu
Postdoctoral Fellow of the American Cancer Society
California Dept. of Health Berkeley, CA.
1983-1986
Postdoctoral Fellow in the US Public Health Service Program
University of California, San Francisco, CA.
1983-1985
Visiting Postdoctoral Fellow
University of Chicago, Chicago, IL.
1986-1987
Research Assistant Professor
University of California, San Francisco, CA.
1988-1991
Assistant Professor of Virology
LSU, School of Veterinary Medicine (SVM).
1991-1994
Associate Professor of Virology
LSU, SVM. Dept. of Microbiol. & Parasitology
1994-Curr.
Professor of Virology & Biotechnology
LSU, SVM. Dept. of Pathobiological Sciences
2004-Curr.
The Mary Lou Martin Professor of Virology
LSU, SVM
2002-Curr.
Director, Division of Biotechnology
LSU, SVM. BIOMMED. & Molecular Medicine (BIOMMED)
2004-Curr.
Director, COBRE Center for Experimental
Infectious Disease Research (CEIDR)
LSU, Baton Rouge
2005-Curr.
Director, Molecular & Cell Biol. Core Idea Network for
Biomedical Research Excellence (INBRE)
LSU, Baton Rouge
Honors:
1972-1975
Honors Program,Phe Zeta Kappa
Fairleigh Dickinson University
1974-1975
Phi Omega Epsilon; Magna*censored*Laude
Fairleigh Dickinson University (B.S. in Physics).
1990
Beecham Award for Research Excellence
SVM, LSU.
1997
Aesculapian Lecturer
SVM, LSU.
1999
Distinguished Faculty Scholar Award
SVM, LSU.
1999
LSU Distinguished Faculty Award
LSU.(for teaching excellence campus-wide).
1999
Certificate of Appreciation for Meritorious
LSU. Service. Council on Research.
2000
The Paula and Milton Shephard Professorship
SVM, LSU.
2001
Salutation for undergraduate teaching excellence
College of Basic Sciences, LSU.
Patents and Patent Applications:
Kousoulas, Konstantin G; Satterlee, Daniel G.; Fioretti, William C. Heterologous protein comprising avian alpha-subunit inhibin protein and methods of producing same. United States Patent 5,786,179. Issued on July 28, 1998
Fioretti, William C; Kousoulas, Konstantin G.; Satterlee, Daniel G. Fusion gene products encoding avian alpha subunit inhibin protein, or an immunogenic fragment thereof, and a carrier protein. United States Patent 5,747,659. Issued on May 5, 1998.
Fioretti, William C; Kousoulas, Konstantin G; Satterlee, Daniel G. Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein. United States Patent 5,725,858. Issued on March 10, 1998.
Emanuele, Martin R.; Newman, M.; Kousoulas, Konstantin G.; Allaudeen Haeedsulthan, S. Therapeutic delivery compositions and methods of use thereof. Issued on August 23, 2005. United States Patent 6,933,286
Kousoulas, Konstantin G.; Chouljenko, Vladimir N.; Baghian, Abolgasem; Tully, Thomas N., Jr. Vaccines for Chlamydia psittaci infections. Unites States Patent 6,605,287. Issued on August 12, 2003.
Major areas of interest:
My primary research interests are focused on the molecular biology and pathogenesis of
herpes simplex viruses (HSV) and human herpesvirus 8 (HHV-8) or Kaposi's Sarcoma Associated Herpesvirus (KSHV). Specifically, I seek to define the molecular mechanisms that control attachment and penetration of these viruses into susceptible cells (including cells of neuronal origin for HSV), their ability to replicate and spread from cell to cell, and the role of membrane fusion events in intracellular virion transport and egress. Our experimental approach utilizes advanced molecular biology, molecular genetics and cell biology. Briefly, mutant herpesviruses deficient in a particular function are isolated through generalized mutagenesis, site-specific mutagenesis of viral genomes cloned into bacterial artificial chromosomes (BAC).These engineered viruses are studied to learn about the role of specific virus encoded proteins in host cell attachment, penetration, virus induced cell fusion virion assembly and egress. To analyze the role of specific viral genes in virus penetration and virus-induced cell fusion these genes are expressed in transient, eukaryotic expression systems and the expressed proteins are detected using specific monoclonal antibodies produced in my laboratory. In addition, monoclonal and monospecific sera against viral proteins are utilized to locate their target proteins in infected cells using confocal and immunoelectron microscopy and to analyze their structure and function. A major finding from our studies has implicated multiple protein-protein interactions among viral membrane proteins of both HSV-1 and KSHV in regulation of virus-induced membrane fusion phenomena. Similarly, multiple interactions among membrane proteins and tegument proteins have been found to regulate cytoplasmic virion envelopment.
A second major interest of my laboratory is the molecular biology and pathogenesis of human and bovine coronaviruses. We have derived and compared the entire genomic nucleotide sequence of several respiratory and enteric bovine coronaviruses and identified specific nucleotide changes, which may be associated with virus tropism. Currently, we are in the final steps of assembling an infectious cDNA of BCV and SARS coronavirus using BAC plasmids. Future experimentation will involve the use of the infectious cDNAs to investigate the molecular determinants of these viruses responsible for their infectivity and spread and their ability to cause virus-induced cell fusion.
A third major interest of my laboratory is the production of vaccines for West Nile virus, herpes B virus and Simian Retrovirus-5 using vesicular stomatitis virus (VSV) and adenovirus-based vectors. This work is carried out in collaboration with the Tulane National Research Primate Center.
Other interests include: the application of DNA based methods for the diagnosis of infectious disease pathogens and genetic diseases of humans and animals, biophysical and genetic approaches to analyze the structure and function of proteins, the use of viruses for gene therapy and vaccine purposes, and the utilization of computers for biological research and teaching.
Teaching Philosophy:
We live in an era that demands change in the way teaching of molecular biology, biotechnology and related disciplines is performed for undergraduate, medical and veterinary and graduate level courses. The rapid growth of molecular biological knowledge is itself a powerful force for change. Biotechnology is heavily dependent on molecular biology and genetic principles as well as increasingly focusing on concepts that cut across scientific fields including chemistry, physics, mathematics and information science. I believe that classroom and laboratory instruction need to adapt to these changing times by emphasizing flexibility, critical thinking and problem solving in an interactive and friendly environment that places students and faculty as partners working side-by-side in learning.
Last Updated Tuesday, September 23 2008 @ 03:26 PM CDT|57,488 Hits